Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc."
Results 161 - 180
of 287
Sorted by Relevance
|
Sort by Date
3 Sep 2019, 5:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
12 Nov 2019, 5:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
18 Jan 2007, 10:48 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
28 Apr 2011, 9:12 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L. [read post]
12 May 2011, 8:10 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L. [read post]
21 Jun 2011, 4:52 am
Merrell Dow Pharmaceuticals, Inc., 509 U. [read post]
23 Jun 2010, 3:35 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S. [read post]
5 Nov 2008, 8:48 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993)] analysis. [read post]
6 Jan 2017, 6:28 am
Merrell Dow Pharmaceuticals,Inc., 509 U.S. 579 (1993). [read post]
18 Apr 2012, 1:14 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) provided a number of factors that typically 'bear on the inquiry'. [read post]
13 May 2020, 2:03 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 592 n.10 (1993). [3] Id., citing Bourjaily v. [read post]
18 Mar 2011, 10:04 am
Merrell Dow Pharm., Inc., 911 F.2d 941, 958-9 (3d Cir. 1990) Daubert v. [read post]
15 Aug 2019, 5:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) (which sets forth an enumerated list of factors, including general acceptance within the scientific community, to consider when evaluating an expert’s opinion). [read post]
4 Apr 2016, 10:06 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), and its progeny set the standards for the admissibility of expert reports and testimony. [read post]
19 Oct 2017, 6:00 am
Merrell Dow Pharmaceuticals, Inc. and its progeny established the governing standard for the admissibility of expert witness testimony in federal courts. [read post]
5 Apr 2022, 5:00 am
Merrell Dow Pharmaceuticals, Inc. [read post]
5 May 2013, 12:15 pm
Merrell Dow Pharmaceuticals, Inc. [read post]
7 Sep 2020, 11:33 am
Merrell Dow Pharmaceuticals, Inc., the Supreme Court held that Federal Rule of Evidence superseded Frye’s general acceptance test. [read post]
23 Jul 2014, 7:24 am
Merrell Dow Pharmaceuticals, Inc. (509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 [1993]).Admissibility of Securities Expert Witness:In a memorandum opinion, Judge F. [read post]
8 Sep 2014, 10:36 pm
Merrell Dow Pharmaceuticals, Inc. (509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 [1993]),The U.S. [read post]